Tanjina Kader

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
No aliases are listed.
Publication record
33 papers · 404 citations · H-index 11

PAPERS

Reconstruction of epithelial transcriptional trajectories reveals heterogeneous progression and early therapy-resistance programs in high-grade serous carcinoma precursors
20260 citationsauthor #3
Abstract IA009: Immune suppression in the fallopian tube: Insights from the pre-cancer atlas
20250 citationsauthor #1
Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression
20251 citationsauthor #1
ZNFX1 functions as a master regulator of epigenetically induced pathogen mimicry and inflammasome signaling in cancer.
20253 citationsauthor #17
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
20246 citationsauthor #1
Abstract LB311: Multimodal spatial profiling reveals the emergence of an immune suppressive microenvironment at the initial stages of high-grade serous ovarian cancer development
20240 citationsauthor #1
Stromal lymphocytes are associated with upgrade of B3 breast lesions
20240 citationsauthor #1
ZNFX1 is a Novel Master Regulator in Epigenetically-induced Pathogen Mimicry and Inflammasome Signaling in Cancer
20240 citationsauthor #17
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
202414 citationsauthor #1
Evaluating statistical approaches to define clonal origin of tumours using bulk DNA sequencing: context is everything
20228 citationsauthor #1
Utility of stromal lymphocytes in diagnosis and predicting upgrade of B3 breast lesions from core biopsies
20220 citationsauthor #1
Abstract 43: Predictive biomarkers of recurrence may not be useful for deescalating treatment of breast ductal carcinoma in situ due to de novo ipsilateral breast carcinoma development
20220 citationsauthor #1
Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus
202116 citationsauthor #2
Ribose-cysteine protects against the development of atherosclerosis in apoE-deficient mice
202011 citationsauthor #1
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
20201 citationsauthor #7
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
202037 citationsauthor #7
The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma
202025 citationsauthor #1
The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma
202025 citationsauthor #2
Abstract P6-10-21: Evaluation of genomic changes in ductal carcinomain situas potential biomarkers of recurrence risk
20200 citationsauthor #6
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density
202010 citationsauthor #18
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density
202010 citationsauthor #19
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density
20201 citationsauthor #11
Identification and molecular characterisation of high-risk pre-malignant breast lesions
20190 citationsauthor #1
Molecular comparison of interval and screen‐detected breast cancers
201921 citationsauthor #9
Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma
201928 citationsauthor #1
Abstract P3-04-08: Genomic analysis of breast papillomas
20180 citationsauthor #2
Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
201859 citationsauthor #1
Abstract PD1-12: Identification of copy number alterations associated with the progression of high risk premalignant breast lesions to breast carcinoma
20180 citationsauthor #1
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer
201752 citationsauthor #5
Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue
201649 citationsauthor #1
Ribose-cysteine increases glutathione-based antioxidant status and reduces atherosclerosis in apoE-deficient mice
20160 citationsauthor #2
Ribose-cysteine increases glutathione-based antioxidant status and reduces LDL in human lipoprotein(a) mice.
201429 citationsauthor #1
The effect of riboceine on lipoprotein(a)
20130 citationsauthor #1

TIMELINE

2013 0 citations

2014 29 citations

2016 49 citations

2017 52 citations

2018 59 citations

2019 49 citations

2020 85 citations

2021 16 citations

2022 8 citations

2024 20 citations

2025 4 citations

2026 0 citations

Tanjina Kader

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT